Combined Chromium With Letrozole Versus Letrozole Only in Induction of Ovulation in Patients With Polycystic Ovary Syndrome

Completed

• Conditions: Polycystic Ovary Syndrome
• Interventions: Drug: Letrozole with chromium

• Registration Number: NCT05765305
• Lead Sponsor: Cairo University

Brief Summary

Combined letrozole with chromium versus letrozole only in induction of ovulation in polycystic ovary syndrome

Detailed Description

Randomized controlled trial

Study Timeline

• Study Start: 2018-09-01
• Primary Completion: 2019-10-01
• Study Completion: 2019-10-01
• Status Verified: 2023-02
• Study First Submitted: 2023-03-01
• Study First Submitted QC: 2023-03-01
• Study First Posted: 2023-03-13
• Last Update Submitted: 2023-03-13
• Last Update Posted: 2023-03-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

• female patients aged from 18 to 35 years Anovulatory cycles Pcos

Exclusion Criteria

• female patients aged more than 35years Male factor of infertility Other factors of infertility than pcos

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Letrozole	Letrozole with chromium	Letrozole versus letrozole with chromium

Primary Outcome Measures

Name	Time	Method
Efficacy of letrozole	12 months	efficacy of letrozole with chromium in improving induction of ovulation

Secondary Outcome Measures

Name	Time	Method
Miscarriage rate	12 months	Incidence of OHSS

Trial Locations

Locations (1)

Faculty of medicine; 🇪🇬 Cairo, القاهره, Egypt